Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of “Buy” by Brokerages

Omada Health, Inc. (NASDAQ:OMDA) has earned a consensus recommendation of “Buy” from the seven ratings firms that are covering the company, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $23.86.

OMDA has been the topic of several research reports. JPMorgan Chase & Co. initiated coverage on Omada Health in a report on Tuesday, July 1st. They issued an “overweight” rating and a $19.00 price target on the stock. The Goldman Sachs Group initiated coverage on Omada Health in a report on Tuesday, July 1st. They issued a “buy” rating and a $29.00 price target on the stock. Needham & Company LLC initiated coverage on Omada Health in a report on Tuesday, July 1st. They issued a “buy” rating and a $23.00 price target on the stock. Canaccord Genuity Group initiated coverage on Omada Health in a report on Tuesday, July 1st. They issued a “buy” rating and a $27.00 price target on the stock. Finally, Wall Street Zen raised Omada Health to a “hold” rating in a report on Monday, June 16th.

Institutional Trading of Omada Health

An institutional investor recently bought a new position in Omada Health stock. Sanofi bought a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 524,903 shares of the company’s stock, valued at approximately $9,606,000. Omada Health accounts for 5.5% of Sanofi’s investment portfolio, making the stock its 5th biggest position. Sanofi owned 2.04% of Omada Health at the end of the most recent quarter.

Omada Health Trading Down 2.8%

NASDAQ OMDA opened at $17.68 on Friday. Omada Health has a 1 year low of $14.14 and a 1 year high of $28.40.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.